Law Steven, Gillmore Julian, Gilbertson Janet A, Bass Paul, Salama Alan D
UCL Department of Renal Medicine, Centre for Experimental Nephrology, Royal Free Hospital, NW3 2PF, London, UK.
National Amyloidosis Centre, Division of Medicine, University College London, NW3 2PF, London, UK.
BMC Nephrol. 2020 Feb 28;21(1):74. doi: 10.1186/s12882-020-01733-9.
Karyomegalic interstitial nephritis (KIN) is a rare hereditary cause of chronic kidney disease. It typically causes progressive renal impairment with haemoproteinuria requiring renal replacement therapy before 50 years of age. It has been associated with mutations in the Fanconi anaemia-associated nuclease 1 (FAN1) gene and has an autosomal recessive pattern of inheritance. Leukocyte chemotactic factor 2 amyloidosis (ALECT2) is the third most common cause of amyloid nephropathy presenting with chronic kidney disease and variable proteinuria. We report a novel mutation in the FAN1 gene causing KIN and to our knowledge, the first case of concurrent KIN and ALECT.
We describe the case of 44 year old Pakistani woman, presenting with stage four non-proteinuric chronic kidney disease, and a brother on dialysis. Renal biopsy demonstrated KIN and concurrent ALECT2. Genetic sequencing identified a novel FAN1 mutation as the cause of her KIN and she is being managed conservatively for chronic kidney disease. Her brother also had KIN with no evidence of amyloidosis and is being worked up for kidney transplantation.
This case highlights two rare causes of chronic kidney disease considered underdiagnosed in the wider population due to their lack of proteinuria, and may contribute to the cohort of patients reaching end stage renal disease without a renal biopsy. We report a novel mutation of the FAN1 gene causing KIN, and report the first case of concurrent KIN and ALECT2. This case highlights the importance of renal biopsy in chronic kidney disease of unclear aetiology which has resulted in a diagnosis with implications for kidney transplantation and family planning.
核仁肿大性间质性肾炎(KIN)是慢性肾脏病一种罕见的遗传病因。它通常导致进行性肾功能损害并伴有血红蛋白尿,患者在50岁前即需要肾脏替代治疗。它与范可尼贫血相关核酸酶1(FAN1)基因突变有关,呈常染色体隐性遗传模式。白细胞趋化因子2淀粉样变性(ALECT2)是导致慢性肾脏病并伴有蛋白尿多变的淀粉样肾病的第三大常见病因。我们报告了一例FAN1基因新突变导致KIN的病例,据我们所知,这是首例同时患有KIN和ALECT2的病例。
我们描述了一名44岁巴基斯坦女性的病例,她患有4期非蛋白尿性慢性肾脏病,其兄弟正在接受透析治疗。肾活检显示为KIN并伴有ALECT2。基因测序确定了一种新的FAN1突变是她患KIN的病因,她目前正在接受慢性肾脏病的保守治疗。她的兄弟也患有KIN,但无淀粉样变性证据,正在接受肾脏移植评估。
该病例凸显了慢性肾脏病的两种罕见病因,由于缺乏蛋白尿,在更广泛人群中被认为诊断不足,可能导致一部分患者在未进行肾活检的情况下发展至终末期肾病。我们报告了一种导致KIN的FAN1基因新突变,并报告了首例同时患有KIN和ALECT2的病例。该病例凸显了肾活检在病因不明的慢性肾脏病中的重要性,其诊断结果对肾脏移植和计划生育具有重要意义。